http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2010064435-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8139 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
filingDate | 2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2010064435-A1 |
titleOfInvention | Method for measuring cystatin C in human body fluid |
abstract | Compared to conventional measurement methods that used a large amount of low-specificity polyclonal antibodies and monoclonal antibodies that have high specificity but weak aggregation properties, they are highly specific, low-cost and easy to automate in human body fluids. A particle-enhanced immunoassay method for cystatin C is provided. High-affinity anti-human cystatin C monoclonal antibody was combined with antibody-sensitized particles in which an anti-human cystatin C monoclonal antibody having a different recognition site and relatively low affinity was independently bound to insoluble carrier particles. A method for measuring cystatin C specific in a human body fluid, wherein the binding amount of anti-human cystatin C monoclonal to the weight of each antibody-sensitized particle is less than 5% by weight. |
priorityDate | 2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.